Mediorals Laboratories Llp - Company Profile

It is a pharma limited liability partnership based in Mumbai, Maharashtra, India, established in 2017.
2017 Mumbai, Maharashtra, India Struck Off
Last Updated:
About Mediorals Laboratories Llp

Mediorals Laboratories Llp, a struck off limited liability partnership, was established on 12 February 2017 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds LLPIN: AAI-5407. Registered under ROC Roc Mumbai. It has total obligation of contribution of ₹2.54 Cr.

Its leadership includes Shirin Hamied (Partner), Rumana Hamied (Partner), Shonaal Amar Lulla (Partner). Its latest date of accounts and solvency statement 31 March 2019. It is based at 12, Hornby View, Rustom Sidhwa Marg(Previously Gunbow Street) Handloom House, Fort, Mumbai, Maharashtra, 400001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAI-5407

  • Incorporation Date

    12 February 2017

  • Total Obligation of Contribution

    ₹2.54 Cr

  • ROC Code

    Roc Mumbai

  • Company Status

    Struck Off

Key Metrics
  • Obligation of Contribution ₹ 2.54 Cr
  • Company Age 8 Year, 11 Months
  • Last Filing with ROC 31 Mar 2019
Company report

Mediorals Laboratories Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Mediorals Laboratories Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Mediorals Laboratories Llp?
Current Designated Partners
Name Designation Appointment Date Status
Shirin Hamied Partner 12 Feb 2017 Current
Rumana Hamied Partner 12 Feb 2017 Current
Shonaal Amar Lulla Partner 12 Feb 2017 Current
Srinivas Hariharan Designated Partner 12 Feb 2017 Current
Geeta Amar Lulla Partner 12 Feb 2017 Current
Shankar Srinivasan Designated Partner 12 Feb 2017 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Mediorals Laboratories Llp.

Enhance accessibility to Mediorals Laboratories Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Mediorals Laboratories Llp revenue growth over time
Mediorals Laboratories Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Mediorals Laboratories Llp?

Unlock access to Mediorals Laboratories Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Mediorals Laboratories Llp?

Unlock and access historical data on people associated with Mediorals Laboratories Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Mediorals Laboratories Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mediorals Laboratories Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Mediorals Laboratories Llp
Recent Activity within the Organization
  • Annual General Meeting

    Mediorals Laboratories Llp last Annual general meeting of members was held on 31 Mar 2019 as per latest MCA records. was recorded as a recent event.

  • Statement of Assets & Liabilities

    Mediorals Laboratories Llp has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    Shirin Hamied was appointed as a Partner was appointed as a Partner on 12 Feb 2017 & has been associated with this company since 8 years 11 months . was recorded as a recent event.

  • Director Appointment

    Rumana Hamied was appointed as a Partner was appointed as a Partner on 12 Feb 2017 & has been associated with this company since 8 years 11 months . was recorded as a recent event.

  • Director Appointment

    The activity Shonaal Amar Lulla was appointed as a Partner was appointed as a Partner on 12 Feb 2017 & has been associated with this company since 8 years 11 months . was completed.

  • Director Appointment

    Srinivas Hariharan was appointed as a Designated Partner was appointed as a Designated Partner on 12 Feb 2017 & has been associated with this company since 8 years 11 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Mediorals Laboratories Llp?

The LLPIN of Mediorals Laboratories Llp is AAI-5407.

Where is Mediorals Laboratories Llp headquartered?

Mediorals Laboratories Llp is headquartered at 12, Hornby View, Rustom Sidhwa Marg(Previously Gunbow Street) Handloom House, Fort, Mumbai, Maharashtra, 400001.

When was Mediorals Laboratories Llp incorporated?

Mediorals Laboratories Llp was incorporated on 12 February 2017.

Who are the current directors of Mediorals Laboratories Llp?
What is the primary industry of Mediorals Laboratories Llp?

The primary industry of Mediorals Laboratories Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available